Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1992-03-06
1999-11-02
Smith, Lynette F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241841, 4242041, 4242081, 4351723, 4352351, 530326, A61K 3921, A61K 3938, A61K 3912, C12N 1500
Patent
active
059765410
ABSTRACT:
Peptides having high activity in the eliciting of a cytotoxic T lymphocyte response to the HIV-1 envelope glycoprotein gpl60 are described. The activation of 12-15 residue peptides by proteolytic degradation to shorter peptides is shown as are general techniques for characterizing such activation processes.
REFERENCES:
patent: 5013548 (1991-05-01), Haynes et al.
patent: 5019387 (1991-05-01), Haynes et al.
patent: 5562905 (1996-10-01), Kenealy et al.
"Serum angiotensin-1 converting enzyme . . . by major Histocompability Complex Class I molecules", S. Kozlowski et al, Journal of Experimental Medicine, vol. 175, No. 6, Jun. '92, pp. 1417-1422.
"A unique subunit immunogen . . . CD8-positive CTLs", H. Takahashi et al, Vaccines 91, 1991, Cold Spring harbor Laboratory, pp. 1-7.
"Induction of cytotoxic T cells to HIV proteins", J. Berzofsky et al, Aids Research and Human Retroviruses, vol. 7, No. 2, Feb. 1991, p. 144.
"An immunodominant class I-restricted . . . class II-restricted help for itself", H. Takahashi et al., Journal of Experimental Medicine, vol. 171, No. 2, Feb. 1990, pp. 571-576.
"A component of fetal calf . . . into its active form", S. Kozlowski et al, Journal of Cellular Biochemistry, No. 16D, Mar. 1992, p. 66.
Berzofsky et al., "Method to Induce Cytotoxic T Lymphocytes Specific for a Broad Array of HIV-1 Isolates Using Hybrid Synthetic Peptides", Gov't of the USA, Dept. of Health and Human Services, Sep. 18, 1991.
Takahashi et al, The Journal of Exp. Med., vol. 170, pp. 2023-2035 (1989).
Fundamental Immunology, Second Edition, Edited by Williams E. Paul, M.D., Raven Press Ltd., New York (1989).
Benjamin et al, Ann. Rev. Immunol., 2:67-101 (1984).
Kast et al, J. Exp. Med., 164:723-738 (1986).
Chakrabarti et al, Nature, 320:535-537 (1986).
Bennink et al, Nature, 311:578-579 (1984).
Houghten, Proc. Natl. Acad. Sci. USA, 82:5131-5135 (1985).
Takahashi, H. et al., Science, 246:118-121, 1989.
Cease, et al., Proc. Natl. Acad. Sci., U.S.A., 84; 4249-4253, Jun. 1987.
Ratner, et al., Nature, 313; 277-284, Jan. 1985.
De Lisi, et al., Proc. Natl. Acad. Sci., U.S.A., 82; 7048-7052, Oct. 1985.
Happ, et al., Proc. Natl. Acad. Sci., USA, 78(6); 3824-3828, Jun. 1981.
Hopp, J. of Immunological Methods; 88; 1-18; 1986.
Chau, et al., Biochem., 13(2); 211-221, Jan. 1974.
Chou, et al., Ann. Rev. Biochem., 47; 251-76; 1978.
Kozlowsky et al, Keystone Symposium on Antigen Presentation: Function of the MHC. TAOS NM Mar. 5-11, 1992. 66. Abstract.
Takahashi et al, "In Immunodominant epitopes of the (HIV)(env) Glyoprotein gp160 recognized by Class I(MHC) Molecule-restordel Murine (CTL)." PNAS. 85, pp. 3105-3108, May 1988.
Fultz, PN et al "Infection of Non-Human Primates with Human and Simian Immunodefiency Viruses" AIDS Vaccine Research and Clincial Trials. Putney SD et al Editors NY 1990 p. 339-49 abstract.
Hilleman, M.R. "Conclusions: In Pursut of an AIDS Viruses Vaccine" Abstract, Immunol Ser. 44:605-20, 1989.
Echberg, J.W. "Experience with 13 HIV Efficieny trials in Chimpanzees" Int Confon AIDS Jun. 20-23, 1990, 6(1) p. 204, Abstract Th.A.338.
Fauci, A.S. et al "Development and Evaluation of a Vaccine for HIV Infection" Ann. Int Med. May 1, 1989, 110(5) pp. 373-385.
Berzofsky Jay A.
Kozlowski Steven
Margulies David H.
Pendleton C. David
Shirai Mutsunori
Nelson Brett
Smith Lynette F.
The United States of America as represented by the Department of
LandOfFree
Potent peptide for stimulation of cytotoxic T lymphocytes specif does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Potent peptide for stimulation of cytotoxic T lymphocytes specif, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potent peptide for stimulation of cytotoxic T lymphocytes specif will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2131542